
Breast cancer is the most researched disease globally, yet there are still significant gaps in equity and access to care and treatments.

Gen Li, PhD, MBA, is the president and founder of Phesi, a clinical data company utilizing AI-driven solutions to optimize clinical trial data for sponsors and providers to improve patient care and treatments.

Breast cancer is the most researched disease globally, yet there are still significant gaps in equity and access to care and treatments.

The founder and President of Phesi addresses the need for streamlining clinical trial data as GLP-1 RA therapies are being used to treat multiple diseases.

Digital patient profiles and expansive real-world data are reshaping oncology clinical trials, explained Gen Li, PhD, MBA, president and founder of Phesi.

Published: October 14th 2025 | Updated:

Published: August 4th 2025 | Updated:

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512
© 2025 MJH Life Sciences®
All rights reserved.
